Cargando…
In host evolution of beta lactam resistance during active treatment for Pseudomonas aeruginosa bacteremia
Multidrug-resistant (MDR) Pseudomonas aeruginosa has been declared a serious threat by the United States Centers for Disease Control and Prevention. Here, we used whole genome sequencing (WGS) to investigate recurrent P. aeruginosa bloodstream infections in a severely immunocompromised patient. The...
Autores principales: | Spottiswoode, Natasha, Hao, Samantha, Sanchez-Guerrero, Estella, Detweiler, Angela M., Mekonen, Honey, Neff, Norma, Macmillan, Henriette, Schwartz, Brian S., Engel, Joanne, DeRisi, Joseph L., Miller, Steven A., Langelier, Charles R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499174/ https://www.ncbi.nlm.nih.gov/pubmed/37712060 http://dx.doi.org/10.3389/fcimb.2023.1241608 |
Ejemplares similares
-
Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia
por: Bliziotis, Ioannis A., et al.
Publicado: (2011) -
A 2-Gene Host Signature for Improved Accuracy of COVID-19 Diagnosis Agnostic to Viral Variants
por: Albright, Jack, et al.
Publicado: (2022) -
Prevalence of type-1 interferon autoantibodies in adults with non-COVID-19 acute respiratory failure
por: Ghale, Rajani, et al.
Publicado: (2022) -
Mechanotaxis directs Pseudomonas aeruginosa twitching motility
por: Kühn, Marco J., et al.
Publicado: (2021) -
Clinical Predictors of Pseudomonas aeruginosa Bacteremia in Emergency Department
por: Choi, Yongsoon, et al.
Publicado: (2018)